CN Patent

CN103044432B — 双环杂芳基化合物

Assigned to Takeda Pharmaceuticals USA Inc · Expires 2016-08-03 · 10y expired

What this patent protects

本发明涉及双环杂芳基化合物，其为通式(I)的化合物，以及涉及其制备和用途，其中各个基团如本说明书中所定义。

USPTO Abstract

本发明涉及双环杂芳基化合物，其为通式(I)的化合物，以及涉及其制备和用途，其中各个基团如本说明书中所定义。

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN103044432B
Jurisdiction: CN
Classification: —
Expires: 2016-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceuticals USA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.